Abstract
The identification of brain tumor stem cells (BTSCs) leads to promising progress on brain tumor treatment. For some brain tumors, BTSCs are the driving force of tumor growth and the culprits that make tumor revive and resistant to radiotherapy and chemotherapy. Therefore, it is specifically significant to eliminate BTSCs for treatment of brain tumors. There are considerable similarities between BTSCs and normal neural stem cells (NSCs), and diverse aspects of BTSCs have been studied to find potential targets that can be manipulated to specifically eradicate BTSCs without damaging normal NSCs, including their surface makers, surrounding niche, and aberrant signaling pathways. Many strategies have been designed to kill BTSCs, and some of them have reached, or are approaching, effective therapeutic results. Here, we will focus on advantages in the issue of BTSCs and emphasize on potential therapeutic strategies targeting BTSCs.
Similar content being viewed by others
References
Al-Hajj M, Wicha MS, ito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988. doi:10.1073/pnas.0530291100
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al (2006a) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756–760. doi:10.1038/nature05236
Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB et al (2006b) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66:7843–7848. doi:10.1158/0008-5472.CAN-06-1010
Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W et al (2007) Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25:2524–2533. doi:10.1634/stemcells.2007-0166
Baron M (2003) An overview of the Notch signalling pathway. Semin Cell Dev Biol 14:113–119. doi:10.1016/S1084-9521(02)00179-9
Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ et al (2007) CD133(+) and CD133(−) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67:4010–4015. doi:10.1158/0008-5472.CAN-06-4180
Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN et al (2002) Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297:1559–1561. doi:10.1126/science.1073733
Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737. doi:10.1038/nm0797-730
Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I et al (1997) Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278:477–483. doi:10.1126/science.278.5337.477
Bruggeman SWM, Hulsman D, Tanger E, Buckle T, Blom M, Zevenhoven J et al (2007) Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 12:328–341. doi:10.1016/j.ccr.2007.08.032
Cai C, Thorne J, Grabel L (2008) Hedgehog serves as a mitogen and survival factor during embryonic stem cell neurogenesis. Stem Cells 26(5):1097–1108
Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B et al (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69–82. doi:10.1016/j.ccr.2006.11.020
Challen GA, Little MH (2006) A side order of stem cells: the SP phenotype. Stem Cells 24:3–12. doi:10.1634/stemcells.2005-0116
Chen HL, Panchision DM (2007) Concise review: bone morphogenetic protein pleiotropism in neural stem cells and their derivatives–alternative pathways, convergent signals. Stem Cells 25:63–68. doi:10.1634/stemcells.2006-0339
Chiba S (2006) Notch signaling in stem cell regulation. Stem Cells 24:2437–2447. doi:10.1634/stemcells.2005-0661
Clark PA, Treisman DM, Ebben J, Kuo JS (2007) Developmental signaling pathways in brain tumor-derived stem-like cells. Dev Dyn 236:3297–3308. doi:10.1002/dvdy.21381
Clement V, Sanchez P, de Tribolet N, Radovanovic I, Altaba A (2007) HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17:165–172. doi:10.1016/j.cub.2006.11.033
Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469–480. doi:10.1016/j.cell.2006.10.018
Clifford SC, Lusher ME, Lindsey JC, Langdon JA, Gilbertson RJ, Straughton D et al (2006) Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Cell Cycle 5:2666–2670
Colak D, Mori T, Brill MS, Pfeifer A, Falk S, Deng C et al (2008) Adult neurogenesis requires Smad4-mediated bone morphogenic protein signaling in stem cells. J Neurosci 28:434–446. doi:10.1523/JNEUROSCI.4374-07.2008
Dahmane N, Sanchez P, Gitton Y, Palma V, Sun T, Beyna M et al (2001) The sonic hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 128:5201–5212
Dakubo GD, Mazerolle CJ, Wallace VA (2006) Expression of Notch and Wnt pathway components and activation of Notch signaling in medulloblastomas from heterozygous patched mice. J Neurooncol 79:221–227. doi:10.1007/s11060-006-9132-2
de la Iglesia N, Konopka G, Puram SV, Chan JA, Bachoo RM, You MJ et al (2008) Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev 22:449–462. doi:10.1101/gad.1606508
Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275–284. doi:10.1038/nrc1590
Dellovade T, Romer JT, Curran T, Rubin LL (2006) The hedgehog pathway and neurological disorders. Annu Rev Neurosci 29:539–563. doi:10.1146/annurev.neuro.29.051605.112858
Dirks P (2007) Bmi1 and cell of origin determinants of brain tumor phenotype. Cancer Cell 12:295–297. doi:10.1016/j.ccr.2007.10.003
Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G et al (2006) Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 13:1238–1241. doi:10.1038/sj.cdd.4401872
Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM et al (2006) Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 66:7445–7452. doi:10.1158/0008-5472.CAN-06-0858
Ferretti E, De SE, Di ML, Screpanti I, Gulino A (2005) Hedgehog checkpoints in medulloblastoma: the chromosome 17p deletion paradigm. Trends Mol Med 11:537–545. doi:10.1016/j.molmed.2005.10.005
Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M, De MM, Autiero M, Wyns S, Plaisance S, Moons L, van RN, Giacca M, Stassen JM, Dewerchin M, Collen D, Carmeliet P (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131:463–475. doi:10.1016/j.cell.2007.08.038
Folkins C, Man S, Xu P, Shaked Y, Hicklin DJ, Kerbel RS (2007) Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res 67:3560–3564. doi:10.1158/0008-5472.CAN-06-4238
Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De VS et al (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011–7021. doi:10.1158/0008-5472.CAN-04-1364
Galvin KE, Ye H, Erstad DJ, Feddersen R, Wetmore C (2008) Gli1 induces G2/M arrest and apoptosis in hippocampal but not tumor-derived neural stem cells. Stem Cells 26(4):1027–1036
Groszer M, Erickson R, Scripture-Adams DD, Dougherty JD, Le Belle J, Zack JA et al (2006) PTEN negatively regulates neural stem cell self-renewal by modulating G0–G1 cell cycle entry. Proc Natl Acad Sci USA 103:111–116. doi:10.1073/pnas.0509939103
Groszer M, Erickson R, Scripture-Adams DD, Lesche R, Trumpp A, Zack JA et al (2001) Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294:2186–2189. doi:10.1126/science.1065518
Guan Y, Gerhard B, Hogge DE (2003) Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 101:3142–3149. doi:10.1182/blood-2002-10-3062
Gulino A, Di Marcotullio L, Ferretti E, De Smaele E, Screpanti I (2007) Hedgehog signaling pathway in neural development and disease. Psychoneuroendocrinology 32:S52–S56. doi:10.1016/j.psyneuen.2007.03.017
Gutierrez A, Look AT (2007) NOTCH and PI3 K-AKT pathways intertwined. Cancer Cell 12:411–413. doi:10.1016/j.ccr.2007.10.027
Hall AK, Miller RH (2004) Emerging roles for bone morphogenetic proteins in central nervous system glial biology. J Neurosci Res 76:1–8. doi:10.1002/jnr.20019
Hamburger AW, Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197:461–463. doi:10.1126/science.560061
He F, Ge W, Martinowich K, Becker-Catania S, Coskun V, Zhu W, Wu H, Castro D, Guillemot F, Fan G, de VJ, Sun YE (2005) A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat Neurosci 8:616–625. doi:10.1038/nn1440
Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M et al (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100:15178–15183. doi:10.1073/pnas.2036535100
Hill RP (2006) Identifying cancer stem cells in solid tumors. Case not proven. Cancer Res 66:1891–1896
Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U et al (2004) A distinct “side population” of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101:14228–14233. doi:10.1073/pnas.0400067101
Holland EC (2000) Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA 97:6242–6244. doi:10.1073/pnas.97.12.6242
Hopewell JW, Wright EA (1969) The importance of implantation site in cerebral carcinogenesis in rats. Cancer Res 29:1927–1931
Huntly BJ, Gilliland DG (2005) Leukemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer 5:311–321. doi:10.1038/nrc1592
Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39:193–206. doi:10.1002/glia.10094
Ille F, Sommer L (2005) Wnt signaling: multiple functions in neural development. Cell Mol Life Sci 62:1100–1108. doi:10.1007/s00018-005-4552-2
Jones SE, Hamburger AW, Kim MB, Salmon SE (1979) Development of a bioassay for putative human lymphoma stem cells. Blood 53:294–303
Jozwiak J, Kotulska K, Grajkowska W, Jozwiak S, Zalewski W, Oldak M et al (2007) Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas. Brain Dev 29:273–280. doi:10.1016/j.braindev.2006.09.009
Kanamori M, Kawaguchi T, Nigro JM, Feuerstein BG, Berger MS, Miele L et al (2007) Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg 106:417–427. doi:10.3171/jns.2007.106.3.417
Kang KB, Wang TT, Woon CT, Cheah ES, Moore XL, Zhu C et al (2007) Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis. Int J Radiat Oncol Biol Phys 67:888–896. doi:10.1016/j.ijrobp.2006.09.055
Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A (2007) Tumor growth need not be driven by rare cancer stem cells. Science 317:337. doi:10.1126/science.1142596
Kim JYH, Nelson AL, Algon SA, Graves O, Sturla LM, Goumnerova LC et al (2003) Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice. Dev Biol 263:50–66. doi:10.1016/S0012-1606(03)00434-2
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC et al (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225
Knobbe CB, Merlo A, Reifenberger G (2002) Pten signaling in gliomas. Neuro-oncol 4:196–211. doi:10.1215/15228517-4-3-196
Kondo T, Setoguchi T, Taga T (2004) Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101:781–786. doi:10.1073/pnas.0307618100
Lai K, Kaspar BK, Gage FH, Schaffer DV (2003) Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat Neurosci 6:21–27. doi:10.1038/nn983
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al (1994) A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 367:645–648. doi:10.1038/367645a0
Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM et al (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391–403. doi:10.1016/j.ccr.2006.03.030
Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH et al (2008) Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13:69–80. doi:10.1016/j.ccr.2007.12.005
Lessard J, Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukemic stem cells. Nature 423:255–260. doi:10.1038/nature01572
Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P et al (2004) Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428:337–341. doi:10.1038/nature02385
Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR et al (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5:67. doi:10.1186/1476-4598-5-67
MacDiarmid JA, Mugridge NB, Weiss JC, Phillips L, Burn AL, Paulin RP et al (2007) Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics. Cancer Cell 11:431–445. doi:10.1016/j.ccr.2007.03.012
Machold R, Hayashi S, Rutlin M, Muzumdar MD, Nery S, Corbin JG et al (2003) Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron 39:937–950. doi:10.1016/S0896-6273(03)00561-0
Mellinghoff IK, Cloughesy TF, Mischel PS (2007) PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res 13:378–381. doi:10.1158/1078-0432.CCR-06-1992
Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ et al (2005) Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353:2012–2024. doi:10.1056/NEJMoa051918
Michaelidis T, Lie D (2008) Wnt signaling and neural stem cells: caught in the Wnt web. Cell Tissue Res 331:193–210. doi:10.1007/s00441-007-0476-5
Mimeault M, Hauke R, Mehta PP, Batra SK (2007) Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 11:981–1011. doi:10.1111/j.1582-4934.2007.00088.x
Ming GL, Song H (2005) Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 28:223–250. doi:10.1146/annurev.neuro.28.051804.101459
Mizrak D, Brittan M, Alison MR (2008) CD133: molecule of the moment. J Pathol 214:3–9. doi:10.1002/path.2283
Mizutani Ki, Yoon K, Dang L, Tokunaga A, Gaiano N (2007) Differential notch signalling distinguishes neural stem cells from intermediate progenitors. Nature 449:351–355. doi:10.1038/nature06090
Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R (2005) Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 19:1432–1437. doi:10.1101/gad.1299505
Moore KA, Lemischka IR (2006) Stem cells and their niches. Science 311:1880–1885. doi:10.1126/science.1110542
Nakano I, Saigusa K, Kornblum HI (2008) BMPing off glioma stem cells. Cancer Cell 13:3–4. doi:10.1016/j.ccr.2007.12.018
Nikuseva-Martic T, Beros V, Pecina-Slaus N, Ivan Pecina H, Bulic-Jakus F (2007) Genetic changes of CDH1, APC, and CTNNB1 found in human brain tumors. Pathol Res Pract 203:779–787. doi:10.1016/j.prp.2007.07.009
Nomura M, Nomura M, Yamagishi Si, Harada Si, Yamashima T, Yamashita J, Yamamoto H (1998) Placenta growth factor (PlGF) mRNA expression in brain tumors. J Neurooncol 40:123–130. doi:10.1023/A:1006198422718
Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445–1453. doi:10.2353/ajpath.2007.070011
Oliver TG, Read TA, Kessler JD, Mehmeti A, Wells JF, Huynh TTT et al (2005) Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma. Development 132:2425–2439. doi:10.1242/dev.01793
Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M et al (2007) Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13:1203–1210. doi:10.1038/nm1636
Panchision DM, Pickel JM, Studer L, Lee SH, Turner PA, Hazel TG et al (2001) Sequential actions of BMP receptors control neural precursor cell production and fate. Genes Dev 15:2094–2110. doi:10.1101/gad.894701
Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG (2005) Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+and ABCG2− cancer cells are similarly tumorigenic. Cancer Res 65:6207–6219. doi:10.1158/0008-5472.CAN-05-0592
Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, Kim J et al (2007) Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA 104:4048–4053. doi:10.1073/pnas.0611682104
Pfenninger CV, Roschupkina T, Hertwig F, Kottwitz D, Englund E, Bengzon J et al (2007) CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells. Cancer Res 67:5727–5736. doi:10.1158/0008-5472.CAN-07-0183
Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD et al (2006a) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157–173. doi:10.1016/j.ccr.2006.02.019
Phillips TM, McBride WH, Pajonk F (2006b) The response of CD24(−/low)/CD44+breast cancer-initiating cells to radiation. J Natl Cancer Inst 98:1777–1785
Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G et al (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444:761–765. doi:10.1038/nature05349
Platet N, Mayol JF, Berger F, Herodin F, Wion D (2007) Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line. FEBS Lett 581:1435–1440. doi:10.1016/j.febslet.2007.02.071
Prados MD, Lamborn KR, Chang S, Burton E, Butowski N, Malec M et al (2006) Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Neuro-oncol 8:67–78. doi:10.1215/S1522851705000451
Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J et al (2005) Expression of notch-1 and Its ligands, delta-like-1 and jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 65:2353–2363. doi:10.1158/0008-5472.CAN-04-1890
Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111. doi:10.1038/35102167
Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707–1710. doi:10.1126/science.1553558
Rich JN, Reardon DA, Peery T, Dowell JM, Quinn JA, Penne KL, Wikstrand CJ, Van Duyn LB, Dancey JE, McLendon RE, Kao JC, Stenzel TT, hmed Rasheed BK, Tourt-Uhlig SE, Herndon JE, Vredenburgh JJ, Sampson JH, Friedman AH, Bigner DD, Friedman HS (2004) Phase II trial of gefitinib in recurrent glioblastoma. J Clin Oncol 22:133–142. doi:10.1200/JCO.2004.08.110
Robey R, Polgar O, Deeken J, To K, Bates S (2007) ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev 26:39–57. doi:10.1007/s10555-007-9042-6
Salmaggi A, Boiardi A, Gelati M, Russo A, Calatozzolo C, Ciusani E et al (2006) Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54:850–860. doi:10.1002/glia.20414
Sanai N, varez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353:811–822. doi:10.1056/NEJMra043666
Scharenberg CW, Harkey MA, Torok-Storb B (2002) The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99:507–512. doi:10.1182/blood.V99.2.507
Setoguchi T, Taga T, Kondo T (2004) Cancer stem cells persist in many cancer cell lines. Cell Cycle 3:414–415
Shakhova O, Leung C, Marino S (2005) Bmi1 in development and tumorigenesis of the central nervous system. J Mol Med 83:596–600. doi:10.1007/s00109-005-0682-0
Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N et al (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304:1338–1340. doi:10.1126/science.1095505
Shih AH, Holland EC (2006) Notch signaling enhances nestin expression in gliomas. Neoplasia 8:1072–1082. doi:10.1593/neo.06526
Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821–5828
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401. doi:10.1038/nature03128
Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N et al (2001) PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 93:1246–1256. doi:10.1093/jnci/93.16.1246
Soeda A, Inagaki A, Oka N, Ikegame Y, Aoki H, Yoshimura SI, Nakashima S, Kunisada T, Iwama T (2008) Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J Biol Chem 283(16):10958–10966
Stiles B, Groszer M, Wang S, Jiao J, Wu H (2004) PTEN less means more. Dev Biol 273:175–184. doi:10.1016/j.ydbio.2004.06.008
Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J et al (1999) PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 96:6199–6204. doi:10.1073/pnas.96.11.6199
Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P et al (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8:323–335. doi:10.1016/j.ccr.2005.09.001
van Diepen MT, Eickholt BJ (2008) Function of PTEN during the formation and maintenance of neuronal circuits in the brain. Dev Neurosci 30:59–64. doi:10.1159/000109852
Valk-Lingbeek ME, Bruggeman SW, van LM (2004) Stem cells and cancer; the polycomb connection. Cell 118:409–418. doi:10.1016/j.cell.2004.08.005
Vescovi AL, Galli R, Reynolds BA (2006) Brain tumour stem cells. Nat Rev Cancer 6:425. doi:10.1038/nrc1889
Vick NA, Lin MJ, Bigner DD (1977) The role of the subependymal plate in glial tumorigenesis. Acta Neuropathol 40:63–71. doi:10.1007/BF00688574
Wang JC, Dick JE (2005) Cancer stem cells: lessons from leukemia. Trends Cell Biol 15:494–501. doi:10.1016/j.tcb.2005.07.004
Wang MY, Lu KV, Zhu S, Dia EQ, Vivanco I, Shackleford GM et al (2006) Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. Cancer Res 66:7864–7869. doi:10.1158/0008-5472.CAN-04-4392
Wang J, Wang X, Jiang S, Lin P, Zhang J, Wu Y, Xiong Z, Ren JJ, Yang H (2008) Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme. Cell Mol Neurobiol. doi:10.1007/s10571-008-9273-2
Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A et al (2002) Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 8:979–986. doi:10.1038/nm754
Wiederschain D, Chen L, Johnson B, Bettano K, Jackson D, Taraszka J et al (2007) Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis. Mol Cell Biol 27:4968–4979. doi:10.1128/MCB.02244-06
Xiangpeng Y, James C, Yizhi X, Gentao L, Sebastian W, Daniel LF, Keith LB, Yu JS (2004) Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23:9392. doi:10.1038/sj.onc.1208311
Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H et al (2006) Pten dependence distinguishes hematopoietic stem cells from leukemia-initiating cells. Nature 441:475–482. doi:10.1038/nature04703
Yoon K, Gaiano N (2005) Notch signaling in the mammalian central nervous system: insights from mouse mutants. Nat Neurosci 8:709–715. doi:10.1038/nn1475
Yu JM, Jun ES, Jung JS, Suh SY, Han JY, Kim JY et al (2007) Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett 257:172–181. doi:10.1016/j.canlet.2007.07.011
Zencak D, Lingbeek M, Kostic C, Tekaya M, Tanger E, Hornfeld D, Jaquet M, Munier FL, Schorderet DF, van Lohuizen M, Arsenijevic Y (2005) Bmi1 loss produces an increase in astroglial cells and a decrease in neural stem cell population and proliferation. J Neurosci 25:5774–5783. doi:10.1523/JNEUROSCI.3452-04.2005
Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N et al (2008) Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14:123–129. doi:10.1158/1078-0432.CCR-07-0932
Zhang Z, Schittenhelm J, Guo K, Buhring HJ, Trautmann K, Meyermann R et al (2006) Upregulation of frizzled 9 in astrocytomas. Neuropathol Appl Neurobiol 32:615–624. doi:10.1111/j.1365-2990.2006.00770.x
Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM et al (2007) Loss of [beta]-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12:528–541. doi:10.1016/j.ccr.2007.11.003
Zhao C, Deng W, Gage FH (2008) Mechanisms and functional implications of adult neurogenesis. Cell 132:645–660. doi:10.1016/j.cell.2008.01.033
Zheng X, Shen G, Yang X, Liu W (2007) Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 67:3691–3697. doi:10.1158/0008-5472.CAN-06-3912
Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ et al (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7:1028–1034. doi:10.1038/nm0901-1028
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mao, Xg., Zhang, X. & Zhen, Hn. Progress on Potential Strategies to Target Brain Tumor Stem Cells. Cell Mol Neurobiol 29, 141–155 (2009). https://doi.org/10.1007/s10571-008-9310-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-008-9310-1